Soriano et al. [1] showed that HTLV-I and HTLV-I1 are both present in Spain and that HTLV-I is still mainly associated with individuals visiting or born in endemic areas and HTLV-I1 with drug addicts. French experience acquired by the universal screening of blood donations for antibodies to HTLV-1/11 from July 1991, in continental France, showed that 61% (43/70) of HTLV-I-infected blood donations detected inthe last semester of 199lcamefromindividuals originated from continental France. Twenty-five of them (58%) acquired HTLV-I infection through heterosexual contact with partners originated from endemic areas. However, these blood donations would not have been discarded through the targeted HTLV screening previously in place. In the first semester of 1992, the proportion of HTLV-I-infected blood donations from donors not originated from endemic areas was lower than in 1991. However it reached 39% (14/36). During thisl-year-period (July1991 to July 1992) only 3 blood donors were identified HTLV4 and HTLV=II Infections in French Blood Donors
[1]
M. Leal,et al.
Avoiding Indeterminate Results in HIV‐1 Western Blot Using Synthetic Peptide Assays
,
1993,
Vox sanguinis.
[2]
J. Coste,et al.
Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France
,
1993
.
[3]
J. Coste,et al.
Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.
,
1993,
AIDS.
[4]
V. Soriano,et al.
HTLV‐I and HTLV‐II Infections in Spain
,
1993,
Vox sanguinis.
[5]
S. Kleinman,et al.
Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors
,
1991,
The Lancet.
[6]
F. Lori,et al.
HTLV-II infection in Italian drug abusers
,
1990,
The Lancet.